ATH 16.7% 0.5¢ alterity therapeutics limited

"Review of operations-31December2018(continued) Pipeline...

  1. 181 Posts.
    lightbulb Created with Sketch. 7
    • ReleaseDate:28/02/1916:50
    • Summary:HalfYearlyReportandAccounts
    • PriceSensitive:Yes
    • ViewDocument
    "Review of operations-31December2018(continued)

    Pipeline development from Translational Biology Program Continued progress has been made on identifying new development candidates by Prana’s discovery chemistry group over the reporting period. These product candidates are within new generation chemical scaffolds and have demonstrated key attributes required to address neurodegenerative processes.

    Prana continues to review other potentially suitable opportunities that may be highly attractive and can add significant shareholder value in the medium to longer term. "

    Would the last sentence (which I have bolded) be a reference to the University of Qld paper?

 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
-0.001(16.7%)
Mkt cap ! $26.22M
Open High Low Value Volume
0.6¢ 0.6¢ 0.5¢ $501.4K 91.10M

Buyers (Bids)

No. Vol. Price($)
71 70438990 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 7499794 14
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
0.6¢
  Change
-0.001 ( 8.33 %)
Open High Low Volume
0.6¢ 0.6¢ 0.6¢ 3568393
Last updated 15.59pm 03/05/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.